10/31/2025
WELL is pleased to announce its majority-owned subsidiary Wellstar has entered into agreements to complete a Series B preferred share investment in the aggregate amount of approximately C$62 million at an offering price of C$1.50 per Series B Share. Please read the key highlights below.
📌 WELLSTAR enters into subscription agreements to complete a C$62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Managemen, PICTON Investments and the management team of WELL and WELLSTAR to fund its pre-spinout growth objectives.
📌 The financing is anticipated to close early December, subject to certain closing conditions.
📌 WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40,000 providers across Canada with high quality technology and services that significantly improve patient care.
To learn more details, follow the link below. đź”—
https://ow.ly/w3pT50Xl60K